Modeling the cost-effectiveness of maternal acellular pertussis immunization (aP) in different socioeconomic settings: A dynamic transmission model of pertussis in three Brazilian states

dc.creatorLuz, Paula M.
dc.creatorStruchiner, Claudio J.
dc.creatorKim, Sun-Young
dc.creatorMinamisava, Ruth
dc.creatorAndrade, Ana Lucia S.
dc.creatorSanderson, Colin
dc.creatorRussell, Louise B.
dc.creatorToscano, Cristiana M.
dc.date2021-03-10T19:22:48Z
dc.date2021-03-10T19:22:48Z
dc.date2021
dc.date.accessioned2023-09-26T20:50:48Z
dc.date.available2023-09-26T20:50:48Z
dc.identifierLUZ, Paula M. et al. Modeling the cost-effectiveness of maternal acellular pertussis immunization (aP) in different socioeconomic settings: A dynamic transmission model of pertussis in three Brazilian states. Vaccine, v. 39, n. 1, p. 125-136, 2021
dc.identifier0264-410X
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/46325
dc.identifier10.1016/j.vaccine.2020.09.008
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8864923
dc.descriptionObjectives: Using dynamic transmission models we evaluated the health and cost outcomes of adding acellular pertussis (aP) vaccination of pregnant women to infant vaccination in three Brazilian states that represent different socioeconomic conditions. The primary objective was to determine whether the same model structure could be used to represent pertussis disease dynamics in differing socioeconomic conditions. Methods: We tested three model structures (SIR, SIRS, SIRSIs) to represent population-level transmission in three socio-demographically distinct Brazilian states: São Paulo, Paraná and Bahia. Two strategies were evaluated: infant wP vaccination alone versus maternal aP immunization plus infant wP vaccination. Model projections for 2014-2029 include outpatient and inpatient pertussis cases, pertussis deaths, years of life lost, disability-adjusted life-years (DALYs) lost, and costs (in 2014 USD) of maternal aP vaccination, infant vaccination, and pertussis medical treatment. Incremental cost per DALY averted is presented from the perspective of the Brazilian National Health System. Results: Based on goodness-of-fit statistics, the SIRSIs model fit best, although it had only a modest improvement in statistical quantitative assessments relative to the SIRS model. For all three Brazilian states, maternal aP immunization led to higher costs but also saved infant lives and averted DALYs. The 2014 USD cost/DALY averted was $3068 in Sao Paulo, $2962 in Parana, and $2022 in Bahia. These results were robust in sensitivity analyses with the incremental cost-effectiveness ratios exceeding per capita gross regional product only when the probability that a pertussis case is reported was assumed higher than base case implying more overt cases and deaths and therefore more medical costs. Conclusions: The same model structure fit all three states best, supporting the idea that the disease behaves similarly across different socioeconomic conditions. We also found that immunization of pregnant women with aP is cost-effective in diverse Brazilian states.
dc.formatapplication/pdf
dc.languageeng
dc.publisherElsevier
dc.rightsrestricted access
dc.subjectCost-effectiveness analysis
dc.subjectDynamic transmission models
dc.subjectMaternal immunization
dc.subjectPertussis
dc.titleModeling the cost-effectiveness of maternal acellular pertussis immunization (aP) in different socioeconomic settings: A dynamic transmission model of pertussis in three Brazilian states
dc.typeArticle


Este ítem pertenece a la siguiente institución